Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco
ORPHA:369847CID-10 · G25.5DOENÇA RARA

Hipercinesia refere-se a um aumento na atividade muscular que pode resultar em movimentos excessivos, sejam anormais, normais ou combinados. A hipercinesia é um estado de inquietação excessiva que é apresentado em uma grande variedade de distúrbios que afetam a capacidade de controlar o movimento motor, como a doença de Huntington. É o oposto da hipocinesia, que se refere à diminuição do movimento corporal, como comumente manifestado na doença de Parkinson.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome rara autossômica recessiva associada ao gene TRAPPC11, caracterizada por deficiência intelectual, movimentos hipercinéticos (atetose, tremor), ataxia do tronco, apraxia da fala, disartria, alacrimia, baixa estatura e dificuldades motoras como incapacidade de andar e displasia do quadril.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
5
pacientes catalogados
Início
Childhood
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, RS, ES, RJ +5CID-10: G25.5
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
15 sintomas
💪
Músculos
10 sintomas
🦴
Ossos e articulações
4 sintomas
🫃
Digestivo
4 sintomas
👁️
Olhos
3 sintomas
📏
Crescimento
2 sintomas

+ 19 sintomas em outras categorias

Características mais comuns

55%prev.
Distrofia muscular da cintura escapular/pélvica
Frequente (79-30%)
55%prev.
Movimentos hipercinesia
Frequente (79-30%)
55%prev.
Fadiga muscular induzida por exercício
Frequente (79-30%)
55%prev.
Coreia
Frequente (79-30%)
55%prev.
Distúrbio da marcha
Frequente (79-30%)
55%prev.
Ataxia troncular
Frequente (79-30%)
59sintomas
Frequente (13)
Ocasional (7)
Sem dados (39)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 59 características clínicas mais associadas, ordenadas por frequência.

Distrofia muscular da cintura escapular/pélvicaLimb-girdle muscular dystrophy
Frequente (79-30%)55%
Movimentos hipercinesiaHyperkinetic movements
Frequente (79-30%)55%
Fadiga muscular induzida por exercícioExercise-induced muscle fatigue
Frequente (79-30%)55%
CoreiaChorea
Frequente (79-30%)55%
Distúrbio da marchaGait disturbance
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa5
Últimos 10 anos200publicações
Pico202352 papers
Linha do tempo
2021Hoje · 2026📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

TRAPPC11Trafficking protein particle complex subunit 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage

LOCALIZAÇÃO

Golgi apparatusGolgi apparatus, cis-Golgi network

VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 18

A form of limb-girdle muscular dystrophy characterized by proximal muscle weakness with childhood onset, resulting in gait abnormalities and scapular winging. Serum creatine kinase is increased. A subset of patients may show a hyperkinetic movement disorder with chorea, ataxia, or dystonia and global developmental delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
33.7 TPM
Cérebro - Hemisfério cerebelar
31.5 TPM
Linfócitos
30.9 TPM
Nervo tibial
29.6 TPM
Cerebelo
29.4 TPM
OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type R18intellectual disability-hyperkinetic movement-truncal ataxia syndrometriple-A syndrome
HGNC:25751UniProt:Q7Z392

Variantes genéticas (ClinVar)

242 variantes patogênicas registradas no ClinVar.

🧬 TRAPPC11: NM_021942.6(TRAPPC11):c.3075dup (p.Val1026fs) ()
🧬 TRAPPC11: GRCh38/hg38 4q32.1-35.2(chr4:157628420-189863176)x1 ()
🧬 TRAPPC11: GRCh38/hg38 4q34.3-35.2(chr4:177853624-190036305)x1 ()
🧬 TRAPPC11: NM_021942.6(TRAPPC11):c.254G>A (p.Trp85Ter) ()
🧬 TRAPPC11: NM_021942.6(TRAPPC11):c.661-2A>G ()
Ver todas no ClinVar

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco

Centros para Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
0 papers (10 anos)
#1

Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.

Brain &amp; development2026 Mar 20

Angelman syndrome (AS), a rare neurogenetic disorder affecting approximately 1 in 15,000 live births, results from loss of functional UBE3A gene expression and manifests with severe developmental delay, intellectual disability, absent speech, ataxia, epilepsy, and distinctive behavioral features. Until recently, only symptomatic management was available. This review provides pediatric neurologists with a comprehensive, practice-oriented overview of emerging disease-modifying therapies for AS, focusing on therapeutic approaches advancing through clinical development. The molecular pathophysiology of AS, natural history considerations critical for trial interpretation, and the current evidence for antisense oligonucleotide (ASO) therapies (ION582, GTX-102/apazunersen, rugonersen), gene replacement approaches (MVX-220), and next-generation strategies including CRISPR-based gene editing, artificial transcription factors, small molecules, and novel delivery platforms are reviewed. ASO therapies targeting the UBE3A antisense transcript represent the most clinically advanced approach, with three candidates showing proof-of-concept efficacy in Phase 1/2 studies and two advancing to pivotal Phase 3 trials. Gene replacement therapy offers potential single-administration treatment but faces challenges regarding safety, immune responses, and durability. Next-generation approaches including CRISPR activation, epigenetic editing, and blood-brain barrier-penetrating delivery systems show preclinical promise. Critical challenges include outcome measurement limitations, genotype stratification, long-term safety monitoring, and ensuring equitable access. These advances herald a transformation in AS clinical care and represent a milestone in precision pediatric neurology.

#2

PRPS1 (p.V42L) Mutation in Arts Syndrome Induces Aberrant Neural Stem Cell Development and Neuronal Senescence-Like Phenotype: Rescue by Nicotinamide Mononucleotide Supplementation.

International journal of stem cells2026 Mar 06

Arts syndrome is a rare X-linked recessive neurodevelopmental disorder arising from pathogenic variants in PRPS1, which encodes phosphoribosyl pyrophosphate synthetase 1-an enzyme essential for de novo nucleotide biosynthesis. Affected individuals typically exhibit sensorineural hearing loss, intellectual disability, cerebellar ataxia, and recurrent infections. However, despite the severity of these clinical manifestations, therapeutic interventions remain limited, largely due to an incomplete understanding of the cellular pathophysiology underlying the disorder. In this study, we generated patient-specific induced pluripotent stem cells harboring the PRPS1 p.V42L variant and differentiated them into neural stem cells (NSCs) and neurons to elucidate disease mechanisms and explore potential therapeutic strategies. Patient-derived NSCs demonstrated significantly reduced proliferative capacity, aberrant nuclear morphology, and increased neuronal senescence, while mitochondrial integrity and function were largely preserved. Neurons differentiated from these NSCs exhibited impaired neurite outgrowth and reduced branching complexity, indicative of disrupted neurodevelopmental processes. Notably, supplementation with nicotinamide mononucleotide, a precursor of nicotinamide adenine dinucleotide (NAD+), partially ameliorated defects in NSC proliferation, nuclear architecture, and neuronal morphology. Collectively, these findings delineate key cellular mechanisms underlying PRPS1-associated neurodevelopmental pathology and identify NAD+ metabolic augmentation as a promising therapeutic avenue for Arts syndrome and related PRPS1-mediated disorders.

#3

Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.

Journal of inherited metabolic disease2026 Mar

Aromatic ʟ-amino acid decarboxylase (AADC) deficiency is a rare pediatric neurotransmitter disorder that typically necessitates lifelong care, and that carries a risk of childhood mortality. Eladocagene exuparvovec gene therapy is designed to restore AADC production. Study GT-002 (NCT04903288) is a phase 2, multicenter, open-label trial assessing the pharmacodynamics, safety, and efficacy of eladocagene exuparvovec administered to the putamen bilaterally in pediatric patients with AADC deficiency using a magnetic resonance (MR)-compatible cannula. Patients received eladocagene exuparvovec at 1.8 × 1011 vector genomes via the SmartFlow MR-compatible cannula in a single operative session. Endpoints include the change from baseline in cerebrospinal fluid homovanillic acid levels, motor milestone achievement, and safety. Here we report results from 48 weeks of follow-up. Mean (SD) cerebrospinal fluid homovanillic acid levels increased from baseline (22.5 [32.3] nmol/L; n = 13) to week 48 (55.3 [45.6] nmol/L; change from baseline: 28.3 [13.7] nmol/L; p = 0.0003; n = 9), indicating de novo dopamine production. At baseline (n = 13), all patients showed severe motor developmental delay; at week 48 (n = 12), nine achieved full head control, four could sit unassisted, two could stand with support, and two could walk independently to a toy. Overall, 260 treatment-emergent adverse events were reported in 13 patients; 259 were deemed unrelated and one likely unrelated to the MR-compatible cannula. No treatment-emergent adverse events led to study withdrawal and no deaths occurred. This study provides further evidence of the favorable pharmacodynamic, efficacy, and safety profile of eladocagene exuparvovec in children with AADC deficiency; intraputaminal administration using an MR-compatible cannula was well tolerated. Study GT-002 (NCT04903288) provides further evidence of the favourable pharmacodynamic, efficacy and safety profile of eladocagene exuparvovec gene therapy in children with AADC deficiency over 48 weeks and demonstrates that intraputaminal administration using an MR-compatible cannula was well tolerated, allowing for real-time MRI confirmation of cannula placement and infusate coverage, and for accurate dosing to the putamen.

#4

Expanding the Genetic Landscape of ATXN2 Variants: Insights From a Biallelic Trinucleotide Repeat Expansion in an Acadian Family.

Neurology. Genetics2026 Feb

Spinocerebellar ataxias are a diverse group of autosomal dominant cerebellar ataxias. SCA2 is a complex ataxia with various extracerebellar symptoms, including parkinsonism, dystonia, hyporeflexia, and cognitive impairment. ATXN2 is a modulator of neurologic disease: Expansions of at least 37 CAG (glutamine) repeats are pathogenic for SCA2, while expansions in the intermediate range (30-32) convey risk for the development of neurodegenerative disorders including Parkinson disease and amyotrophic lateral sclerosis. Homozygous variants are exceedingly rare. This study describes a novel ATXN2 presentation identified in an Acadian family from New Brunswick, Canada: a CAG repeat expansion within the fully penetrant range of SCA2, asymptomatic in the heterozygous state and resulting in a neurodegenerative disorder in homozygous patients. Three individuals, 2 siblings and their cousin, were investigated for a neurodegenerative disorder with overlapping phenotypes. The affected individuals and their 5 immediate family members underwent whole-genome sequencing analyzed by ExpansionHunter, repeat-primed PCR and Sanger sequencing. Sequencing revealed a homozygous 39/39 CAG repeat expansion with 4 CAA interruptions in ATXN2 across all 3 affected individuals. After experiencing childhood intellectual or learning difficulties, the patients developed a pyramidal syndrome with spastic gait and a major neurocognitive disorder characterized by prominent frontal signs during their late twenties. Within a decade, all patients completely lost their autonomy. Shared phenotypic features included ataxia, spasticity, aphasia, dysphagia, myoclonus, atypical parkinsonism, incontinence, diffuse cortical atrophy with frontal predominance, and cerebellar atrophy. The same 39 CAG repeat allele with 4 CAA interruptions was identified in heterozygous state in 4 asymptomatic parents (age 65+) and 1 sibling in their thirties. Three carriers consented to further investigation with a neurologic examination, neuropsychological assessment, and cerebral MRI. Clinical and radiologic signs of disease were absent, despite the carriers' ages and their heterozygous expansion in the fully penetrant range of SCA2. This study describes a novel ATXN2 expansion within the classic pathogenic range for SCA2 that manifests as an early-onset neurodegenerative disorder in the homozygous state, while being asymptomatic into late adulthood in the heterozygous state.

#5

Biallelic Novel SKOR2 Variants in Individuals With Cerebellar Hypoplasia and Intellectual Disability, Expanding the Phenotypic Spectrum of Valence-Farazi Cerebellar Ataxia Syndrome.

American journal of medical genetics. Part A2026 Mar 12

The embryonic development of the cerebellum is orchestrated through a dynamic process that governs the interplay of Purkinje and granule cell populations. SKOR2 (Fussel 18) is a transcriptional co-repressor that increases SHH (sonic hedgehog) expression which is a potent signal for granule cell proliferation and integration into the complex neuronal network that underlies cerebellar function and development. Complete loss of Skor2 function in a murine model has been shown to result in cerebellar hypoplasia due to severe disruption of the cerebellar vermis. Through GeneMatcher we identified eight individuals from five unrelated families with compound heterozygous or homozygous loss of function, splice site and missense variants in SKOR2 associated with a phenotypic spectrum of cerebellar hypoplasia, microcephaly, ataxia, developmental delays and intellectual disability. Variants identified in SKOR2 included homozygous c.1877delC; p.Pro626Glnfsx156 in the first individual, homozygous c.2752 + 1G>T in the second and third individuals, compound heterozygous c.757T>G p.C253G, c.949T>A p.S317T in the fourth individual, homozygous c.421_424del (p.Asp141Ilefs*118) in the fifth, sixth, and seventh individuals, and a homozygous c.1169C>A; p.Ser390* in the eighth individual. The eight individuals had various degrees of developmental and speech delays, as well as cerebellar hypoplasia identified in some of them. In silico analysis supported pathogenicity of most of SKOR2 variants, except for case 4, and their impact on protein function. Recently, SKOR2 is reported to be associated with Valence-Farazi Cerebellar Ataxia Syndrome (OMIM # 621386) (Skor2-OMIM-OMIM.ORG). This study expands the phenotypic spectrum for this newly described condition. Additional studies in affected individuals will be needed to refine the phenotypic spectrum and identify genotype-phenotype correlations.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.

Brain &amp; development
2026

Biallelic Novel SKOR2 Variants in Individuals With Cerebellar Hypoplasia and Intellectual Disability, Expanding the Phenotypic Spectrum of Valence-Farazi Cerebellar Ataxia Syndrome.

American journal of medical genetics. Part A
2026

PRPS1 (p.V42L) Mutation in Arts Syndrome Induces Aberrant Neural Stem Cell Development and Neuronal Senescence-Like Phenotype: Rescue by Nicotinamide Mononucleotide Supplementation.

International journal of stem cells
2026

Novel Mutations in KCNJ10 Gene Associated With SeSAME Syndrome: Rare Disorder With Possible Common Mutation.

Molecular genetics &amp; genomic medicine
2026

Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.

Journal of inherited metabolic disease
2026

Duolingo-induced seizures in GAD65 IgG associated autoimmune epilepsy.

Epilepsy &amp; behavior reports
2026

CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder.

Journal of neurochemistry
2026

Expanding the Genetic Landscape of ATXN2 Variants: Insights From a Biallelic Trinucleotide Repeat Expansion in an Acadian Family.

Neurology. Genetics
2026

A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers.

Clinica chimica acta; international journal of clinical chemistry
2025

Spinocerebellar ataxia, autosomal recessive type 23 (SCAR23) with compound TDP2 variants: clinical, molecular, and quantitative follow-up.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Microstructural White Matter Alterations in Angelman Syndrome: A Fixel-Based Analysis.

Autism research : official journal of the International Society for Autism Research
2025

Case Report: developmental delay and intellectual disability linked to a maternally inherited derivative chromosome 3 from a t(3;8) translocation.

Frontiers in genetics
2025

A Novel SIL1 Variant (p.E342K) Associated with Marinesco-Sjögren Syndrome Impairs Protein Stability and Function.

International journal of molecular sciences
2025

WDR81 Mutation in Two Siblings: A Case Report and Review of Literature.

Molecular syndromology
2025

Accumulation of complex I assembly intermediates in a novel presentation of RTN4IP1-related disorder with developmental delay, ataxia and dyskinesia.

Molecular genetics and metabolism
2025

A New Variant in the NALCN Channel Is Responsible for Cerebellar Ataxia and Cognitive Impairment.

Genes
2025

Neurodevelopmental Progression and Functional Outcomes in a Child With Joubert Syndrome: A Case Study.

Cureus
2025

Motor, cognitive, affective, and communication outcomes in patients with sustained remission of opsoclonus-myoclonus-ataxia syndrome.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2025

Neurological, Neuropsychological, and Social Outcomes in Pediatric Patients Diagnosed With Cerebellar Mutism Syndrome: A Systematic Review.

Pediatric blood &amp; cancer
2025

Repurposing Nitazoxanide to target the expanded r(CGG)n repeat RNA for therapeutic intervention in fragile-X tremor/ataxia syndrome.

International journal of biological macromolecules
2025

The Christianson syndrome protein, sodium hydrogen exchanger isoform 6, is required for fat accumulation.

The Journal of physiology
2025

Novel neuropathological observations in an adult with Dravet syndrome.

Epilepsia
2025

Effects of SLC6A8 mutation-induced creatine deficiency on cellular function in fibroblasts.

Scientific reports
2025

Neurological Complications in Inborn Errors of Immunity: A Scoping Review of Clinical Spectrum, Pathophysiological Mechanisms, and Therapeutic Strategies.

Clinical reviews in allergy &amp; immunology
2025

Expanding the Clinical, Pathological, and Molecular Phenotypes of Tetratricopeptide 19 (TTC19) Gene Mutations: A Case Report from India.

Neurology India
2025

[Development of Therapeutic Agents Targeting Higher-order Structures of Nucleic Acids in Neurodegenerative Diseases].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
2025

Developmental and Epileptic Encephalopathy as a Novel Clinical Hallmark of SCA21.

Neuropediatrics
2025

Expansion of the Genotypic and Phenotypic Spectrum of TCTN3-Related Joubert Syndrome.

Genes
2025

[Clinical features and genetic analysis of a child with Christianson syndrome due to variant of SLC9A6 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Dynamic electro-clinical features in Guanidinoacetate N-methyltransferase deficiency: A familial case series.

Epilepsia open
2025

A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

POLR3A rare variants in a patient with intellectual disability, ataxic gait and cortical malformations: a case-report.

Italian journal of pediatrics
2025

CHD8 Variant and Rett Syndrome: Overlapping Phenotypes, Molecular Convergence, and Expanding the Genetic Spectrum.

Human mutation
2025

Early-Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B.

Movement disorders : official journal of the Movement Disorder Society
2025

French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

Revue neurologique
2025

Senior-Loken Syndrome: Ocular Perspectives on Genetics, Pathogenesis, and Management.

Biomolecules
2025

Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome can Lead to Long-Term Neurological, Neuropsychological, and Cognitive Sequelae Associated with Cerebellar Atrophy.

Cerebellum (London, England)
2025

Expanding the spectrum of ATP8A2 mutations: a new splicing variant and systematic review of CAMRQ4 syndrome.

Molecular biology reports
2025

Cerebellar Ataxia-deafness-narcolepsy (ADCA) syndrome. Description of a variable family phenotype.

Acta neurologica Belgica
2025

Effectiveness and Safety of High-Dose Oral Phenobarbital in Children With Recurrent and Treatment-Refractory Seizures.

Clinical pediatrics
2025

Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.

Molecular neurodegeneration
2025

A nonsense variant in the C-terminal transactivation domain of the EBF3 gene in an individual with intellectual disability and behavioural disorder: case report and literature review.

Psychiatric genetics
2025

Cerebellar Ataxia, Impaired Intellectual Development, and Disequilibrium Syndrome-2: A Case Report.

Cureus
2025

Pain experience of children with Christianson syndrome.

Pain
2025

Reevaluation of the Impact of the Novel Likely Pathogenic Variant c.1286_1288delAGA in the ATP8A2 Gene: A 7-Year Follow-Up With Clinical, Genetic, and ACMG Insights in an Iranian Family.

Molecular genetics &amp; genomic medicine
2025

Poretti-Boltshauser Syndrome: A Report of Two Cases From Bahrain With a Novel Mutation and Literature Review.

Cureus
2025

Phenotypic variability in two siblings with Poretti-Boltshauser syndrome.

Global medical genetics
2025

Viral vector-mediated SLC9A6 gene replacement reduces cerebellar dysfunction in the shaker rat model of Christianson syndrome.

bioRxiv : the preprint server for biology
2026

Genetic etiology of Perrault syndrome in Iranian families: first report from Iran and literature review.

Journal of applied genetics
2025

An X-Linked Ataxia Syndrome in a Family with Hearing Loss Associated with a Novel Variant in the BCAP31 Gene.

Movement disorders : official journal of the Movement Disorder Society
2025

Zellweger spectrum disorder presenting with opsoclonus-myoclonus-ataxia syndrome: a case report on immunotherapy.

Acta neurologica Belgica
2025

CHD3-related Snijders Blok-Campeau syndrome with Spastic Paraplegia, Ataxia, and Situs Inversus.

European journal of medical genetics
2025

Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report.

Neurology
2025

Structural and functional properties of the N- and C-terminal segments of the P4-ATPase phospholipid flippase ATP8A2.

The Journal of biological chemistry
2025

Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician.

World journal of pediatrics : WJP
2024

A novel frameshift variant in the SLC2A1 gene causing a mild phenotype of GLUT1 deficiency syndrome: case report.

Molecular genetics and metabolism reports
2025

Expanding the genotypic and phenotypic spectrum of EAST/SeSAME syndrome: identification of a novel homozygous mutation (c.194 G > A) in KCNJ10 gene.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Small Complex Rearrangement in HINT1-Related Axonal Neuropathy.

Genes
2025

WDR45-related encephalopathy mimicking Leigh syndrome associated with complex I deficiency: a case report.

European journal of human genetics : EJHG
2025

Expanding the phenotyping spectrum of Witteveen Kolk syndrome: first report of generalized dystonia and cerebellar ataxia.

Acta neurologica Belgica
2025

De novo missense variants in the PP2A regulatory subunit PPP2R2B in a neurodevelopmental syndrome: potential links to mitochondrial dynamics and spinocerebellar ataxias.

Human molecular genetics
2025

CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability.

Brain : a journal of neurology
2025

Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies.

Clinical genetics
2024

Atlantoaxial Instability due to Os Odontoideum in a Child with Christianson Syndrome.

Molecular syndromology
2024

Tremor-Dominant Movement Disorder in ANKRD11- Associated KBG Syndrome.

Tremor and other hyperkinetic movements (New York, N.Y.)
2025

Impaired hippocampal plasticity associated with loss of recycling endosomal SLC9A6/NHE6 is ameliorated by the TrkB agonist 7,8-dihydroxyflavone.

Biochimica et biophysica acta. Molecular basis of disease
2024

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Journal of clinical immunology
2024

CACNA1G Causes Dominantly Inherited Myoclonus-Ataxia with Intellectual Disability: A Case Report.

Cerebellum (London, England)
2025

Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Christianson syndrome across the lifespan: genetic mutations and longitudinal study in children, adolescents, and adults.

Journal of medical genetics
2024

Phenotypic Spectrum and Natural History of Gillespie Syndrome. An Updated Literature Review with 2 New Cases.

Cerebellum (London, England)
2024

Exome sequencing confirms the clinical diagnosis of both joubert syndrome and klinefelter syndrome with keratoconus in a han Chinese family.

Frontiers in genetics
2024

SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X-Linked Intellectual Disability.

Annals of neurology
2024

A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes.

Neurogenetics
2024

Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia.

Journal of neurology
2024

Fragile X Syndrome and FMR1 premutation: results from a survey on associated conditions and treatment priorities in Italy.

Orphanet journal of rare diseases
2024

The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants.

Clinical genetics
2024

De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity.

Brain : a journal of neurology
2024

NR4A2 as a Novel Target Gene for Developmental and Epileptic Encephalopathy: A Systematic Review of Related Disorders and Therapeutic Strategies.

International journal of molecular sciences
2024

SCN1A-Characterization of the Gene's Variants in the Polish Cohort of Patients with Dravet Syndrome: One Center Experience.

Current issues in molecular biology
2024

Role of fragile X messenger ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective.

Neuroscience and biobehavioral reviews
2024

ITPR1: The missing gene in miosis-ataxia syndrome?

American journal of medical genetics. Part A
2024

Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.

Pediatric blood &amp; cancer
2024

Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia.

Movement disorders : official journal of the Movement Disorder Society
2024

Unmethylated Mosaic Full Mutation Males without Fragile X Syndrome.

Genes
2024

Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency (SLC6A8).

Neurology
2024

Joubert syndrome-derived induced pluripotent stem cells show altered neuronal differentiation in vitro.

Cell and tissue research
2024

Preimplantation genetic testing for monogenic disorders (PGT-M) offers an alternative strategy to prevent children from being born with hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes: a retrospective study.

Journal of assisted reproduction and genetics
2024

Increased Proteolytic Activity of Serratia marcescens Clinical Isolate HU1848 Is Associated with Higher eepR Expression.

Polish journal of microbiology
2024

Functional and in silico analysis of ATP8A2 and other P4-ATPase variants associated with human genetic diseases.

Disease models &amp; mechanisms
2024

Bi-allelic variants in SNF8 cause a disease spectrum ranging from severe developmental and epileptic encephalopathy to syndromic optic atrophy.

American journal of human genetics
2024

Case Report: An Adult Case of Poretti-Boltshauser Syndrome Diagnosed by Medical Checkup.

Cerebellum (London, England)
2024

The effects of response disequilibrium on social media use: A laboratory analogue.

Behavioural processes
2024

Cognitive, Emotional, and Other Non-motor Symptoms of Spinocerebellar Ataxias.

Current neurology and neuroscience reports
2024

Disease-linked mutations in Munc18-1 deplete synaptic Doc2.

Brain : a journal of neurology
2023

IRF2BPL Causes Mild Intellectual Disability Followed by Late-Onset Ataxia.

Neurology. Genetics
2024

Novel compound heterozygous ABCA2 variants cause IDPOGSA, a variable phenotypic syndrome with intellectual disability.

Journal of human genetics
2023

Untangling adaptive functioning of PMM2-CDG across age and its impact on parental stress: a cross-sectional study.

Scientific reports
2023

Compound Heterozygosity in Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome Type 4.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
2023

DNAJC12 deficiency: Mild hyperphenylalaninemia and neurological impairment in two siblings.

Molecular genetics and metabolism reports
2023

Ataxia Syndrome With Hearing Loss and Nephronophthisis Associated With a Novel Homozygous Variant in XPNPEP3.

Neurology. Genetics
2023

The Spectrum of Inherited Gray Matter Degenerative Brain Disorders (DBD) in Children: A Single-Center Study.

Annals of Indian Academy of Neurology
2024

Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study.

Drug and alcohol dependence
2023

[Analysis of clinical features and ATRX gene variants in a Chinese pedigree affected with X-linked alpha thalassemia mental retardation (ATR-X) syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Christianson Syndrome across the Lifespan: An International Longitudinal Study in Children, Adolescents, and Adults.

medRxiv : the preprint server for health sciences
2024

Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design.

Movement disorders : official journal of the Movement Disorder Society
2024

Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.

Brain : a journal of neurology
2023

Stem cell models of Angelman syndrome.

Frontiers in cell and developmental biology
2024

Phenotypic variability in Joubert syndrome is partially explained by ciliary pathophysiology.

Annals of human genetics
2023

Methyl-CpG-Binding protein 2 duplication syndrome in a Chinese patient: A case report and review of the literature.

World journal of clinical cases
2023

Prevalence, Clinical Features, Neuroimaging, and Genetic Findings in Children With Ataxic Cerebral Palsy in Europe.

Neurology
2023

ITPR1-associated spinocerebellar ataxia with craniofacial features-additional evidence for germline mosaicism.

Cold Spring Harbor molecular case studies
2023

Targeting NHE6 gene expression identifies lysosome and neurodevelopmental mechanisms in a haploid in vitro cell model.

Biology open
2023

A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant.

Pharmacogenomics and personalized medicine
2023

ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures.

Genetics in medicine : official journal of the American College of Medical Genetics
2023

Multiple Independent Gene Disorders Causing Bardet-Biedl Syndrome, Congenital Hypothyroidism, and Hearing Loss in a Single Indian Patient.

Brain sciences
2023

Clinical, biochemical, and molecular characterization of mucopolysaccharidosis type III in 34 Egyptian patients.

American journal of medical genetics. Part A
2023

PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients.

Frontiers in pharmacology
2023

Progressive myoclonic epilepsy type 1 (EPM1) patients present with abnormal 1H MRS brain metabolic profiles associated with cognitive function.

NeuroImage. Clinical
2023

Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.

Brain : a journal of neurology
2023

Occupational Therapy Intervention in the Child with Leukodystrophy: Case Report.

Children (Basel, Switzerland)
2023

Homozygous deep intronic variant in SNX14 cause autosomal recessive Spinocerebellar ataxia 20: a case report.

Frontiers in genetics
2023

Behavioural deficits of autism spectrum disorder and associations with different gene clusters: a study with the whole-genome transmission disequilibrium test.

BMJ paediatrics open
2023

Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome.

CNS neuroscience &amp; therapeutics
2023

[Clinical features and genetic analysis of a child with EAST/SeSAME syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

New Insights into the Neuropsychological Profile and Intellectual Quotient Variability in Joubert Syndrome Compared to Other Congenital Cerebellar Malformations.

Cerebellum (London, England)
2023

Rehabilitation Approach for Children With Joubert Syndrome and Related Disorders.

Cureus
2023

Clinical and genetic analysis of Christianson syndrome caused by variant of SLC9A6: case report and literature review.

Frontiers in neurology
2023

Whole-exome sequencing detected a novel AIFM1 variant in a Han-Chinese family with Cowchock syndrome.

Hereditas
2023

Expansion of clinical and variant spectrum of EEF2-related neurodevelopmental disorder: Report of two additional cases.

American journal of medical genetics. Part A
2023

Rare 15q21.1q22.31 Duplication Due to a Familial Chromosomal Insertion and Diagnostic Investigation in a Carrier of Balanced Chromosomal Rearrangement and Intellectual Disability.

Genes
2023

The Gross, Fine, and Oral Motor Functions in a Patient with Megalencephalic Leukoencephalopathy with Subcortical Cyst: A Case Report.

Iranian journal of child neurology
2023

Neurologic, Neuropsychologic, and Neuroradiologic Features of EBF3-Related Syndrome.

Neurology. Genetics
2023

A novel de novo variant in CASK causes a severe neurodevelopmental disorder that masks the phenotype of a novel de novo variant in EEF2.

Journal of human genetics
2023

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.

Brain : a journal of neurology
2023

CERT1 mutations perturb human development by disrupting sphingolipid homeostasis.

The Journal of clinical investigation
2023

Further delineation of EBF3-related syndromic neurodevelopmental disorder in twelve Chinese patients.

Frontiers in pediatrics
2023

Deep Brain Stimulation for the Management of AIFM1-Related Disabling Tremor: A Case Series.

Pediatric neurology
2023

It is more "unbalanced" than you think.

Blood
2023

Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome.

Nature communications
2023

The Mitochondrial tRNASer(UCN) Gene: A Novel m.7484A>G Mutation Associated with Mitochondrial Encephalomyopathy and Literature Review.

Life (Basel, Switzerland)
2022

Joubert syndrome: Molecular basis and treatment.

Journal of mother and child
2023

TELO2-related syndrome (You-Hoover-Fong syndrome): Description of 14 new affected individuals and review of the literature.

American journal of medical genetics. Part A
2023

Homozygous Missense Variant in the N-Terminal Region of ANK3 Gene Is Associated with Developmental Delay, Seizures, Speech Abnormality, and Aggressive Behavior.

Molecular syndromology
2023

Mouse models of fragile X-related disorders.

Disease models &amp; mechanisms
2022

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders.

Genes
2023

Slc9a6 mutation causes Purkinje cell loss and ataxia in the shaker rat.

Human molecular genetics
2024

Suspected Autosomal Recessive Polycystic Kidney Disease but Cerebellar Vermis Hypoplasia, Oligophrenia Ataxia, Coloboma, and Hepatic Fibrosis (COACH) Syndrome in Retrospect, A Delayed Diagnosis Aided by Genotyping and Reverse Phenotyping: A Case Report and A Review of the Literature.

Nephron
2023

Natural History of SURF1 Deficiency: A Retrospective Chart Review.

Pediatric neurology
2023

Phenotypic spectrum of patients with Poretti-Boltshauser syndrome: Patient report of antenatal ventriculomegaly and esophageal atresia.

European journal of medical genetics
2022

A Case of Gillespie Syndrome With Atypical Presentation.

Cureus
2023

CUL4B-associated epilepsy: Report of a novel truncating variant promoting drug-resistant seizures and systematic review of the literature.

Seizure
2022

Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay due to Novel Mutations in the SACS Gene.

Journal of investigative medicine high impact case reports
2023

A KCNC1-related neurological disorder due to gain of Kv3.1 function.

Annals of clinical and translational neurology
2023

Diagnostic value of molecular approach in screening for fragile X premutation cases.

Irish journal of medical science
2022

CTBP1 and CTBP2 mutations underpinning neurological disorders: a systematic review.

Neurogenetics
2022

[Analysis of clinical features and EBF3 gene variant in a child with hypotonia, ataxia and developmental delay].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

A Novel de novo KIF1A Mutation in a Patient with Ataxia, Intellectual Disability and Mild Foot Deformity.

Cerebellum (London, England)
2022

Long-Surviving Adult Siblings With Joubert Syndrome Harboring a Novel Compound Heterozygous CPLANE1 Variant.

Neurology. Genetics
2023

A Systematic Review of Fragile X-Associated Neuropsychiatric Disorders.

The Journal of neuropsychiatry and clinical neurosciences
2022

Case report: Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years.

Frontiers in neurology
2022

Teaching NeuroImage: Selectively Bright Inferior Cerebellum in Christianson Syndrome.

Neurology
2022

Loss of endosomal exchanger NHE6 leads to pathological changes in tau in human neurons.

Stem cell reports
2022

Association between early and current gastro-intestinal symptoms and co-morbidities in children and adolescents with Angelman syndrome.

Journal of intellectual disability research : JIDR
2022

Sleep, Respiration and Nocturnal Paroxysmal Events in Joubert Syndrome: A Case Report.

Nature and science of sleep
2022

Neurodevelopmental disorder with microcephaly, ataxia, and seizures syndrome: expansion of the clinical spectrum.

Clinical dysmorphology
2023

Scoliosis in RETT Syndrome: A National Referral Centre Experience.

Clinical spine surgery
2024

Impact of Deletion on Angelman Syndrome Phenotype Variability: Phenotype-Genotype Correlation in 97 Patients with Motor Developmental Delay.

Journal of pediatric genetics
2022

NUS1 and Epilepsy-myoclonus-ataxia Syndrome: An Under-recognized Entity?

Tremor and other hyperkinetic movements (New York, N.Y.)
2022

Atypical presentation of Angelman syndrome with intact expressive language due to low-level mosaicism.

Molecular genetics &amp; genomic medicine
2022

Cerebellum neuropathology and motor skill deficits in fragile X syndrome.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2022

Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation.

Scientific reports
2022

Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications.

Journal of neurology
2022

Potassium Channel KCNH1 Activating Variants Cause Altered Functional and Morphological Ciliogenesis.

Molecular neurobiology
2022

Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.

Neurochemistry international
2022

Gillespie's Syndrome Phenotype in A Patient with a Homozygous Variant of Uncertain Significance in the ITPR1 Gene.

Neuro-ophthalmology (Aeolus Press)
2022

[The cellular functions of G-quadruplex in neurological diseases].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
2022

A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.

Brain &amp; development
2022

A novel variant in SLC16A2 associated with typical Allan-Herndon-Dudley syndrome: a case report.

BMC pediatrics
2022

EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies.

Frontiers in physiology
2022

Novel Biallelic Variant in the BRAT1 Gene Caused Nonprogressive Cerebellar Ataxia Syndrome.

Frontiers in genetics
2022

A novel TRMT5 mutation causes a complex inherited neuropathy syndrome: The role of nerve pathology in defining a demyelinating neuropathy.

Neuropathology and applied neurobiology
2022

Donor Splice Site Variant in SLC9A6 Causes Christianson Syndrome in a Lithuanian Family: A Case Report.

Medicina (Kaunas, Lithuania)
2022

Expression of FMRpolyG in Peripheral Blood Mononuclear Cells of Women with Fragile X Mental Retardation 1 Gene Premutation.

Genes
2022

Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia.

Cells
2022

Two Siblings with Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome 4 and a Novel Variant of ATP8A2.

The Tohoku journal of experimental medicine
2022

Gait as a quantitative translational outcome measure in Angelman syndrome.

Autism research : official journal of the International Society for Autism Research
2022

Case Report: Stress-Induced Childhood-Onset Neurodegeneration With Ataxia-Seizures Syndrome Caused by a Novel Compound Heterozygous Mutation in ADPRHL2.

Frontiers in neurology
2022

A Novel, Apparently Silent Variant in MFSD8 Causes Neuronal Ceroid Lipofuscinosis with Marked Intrafamilial Variability.

International journal of molecular sciences
2022

Motor and behavioral phenotype of Dravet syndrome in adulthood.

Epilepsy &amp; behavior : E&amp;B
2022

Neurodevelopmental Syndrome with Intellectual Disability, Speech Impairment, and Quadrupedia Is Associated with Glutamate Receptor Delta 2 Gene Defect.

Cells
2022

Identification and functional analysis of two new de novo KCNMA1 variants associated with Liang-Wang syndrome.

Acta physiologica (Oxford, England)
2021

The Essential DNA Damage Response Complex MRN Is Dispensable for the Survival and Function of Purkinje Neurons.

Frontiers in aging neuroscience
2022

De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.

Movement disorders : official journal of the Movement Disorder Society
2022

De Novo ATP1A1 Variants in an Early-Onset Complex Neurodevelopmental Syndrome.

Neurology
2022

Sex-dependent influence of postweaning environmental enrichment in Angelman syndrome model mice.

Brain and behavior
2022

Rhomboencephalosynapsis: Review of the Literature.

World neurosurgery
2022

Epilepsy and Sleep in the ATR-X Syndrome.

Neuropediatrics
2022

Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain.

Brain : a journal of neurology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists.
    Brain &amp; development· 2026· PMID 41864145mais citado
  2. PRPS1 (p.V42L) Mutation in Arts Syndrome Induces Aberrant Neural Stem Cell Development and Neuronal Senescence-Like Phenotype: Rescue by Nicotinamide Mononucleotide Supplementation.
    International journal of stem cells· 2026· PMID 41787648mais citado
  3. Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up.
    Journal of inherited metabolic disease· 2026· PMID 41724580mais citado
  4. Expanding the Genetic Landscape of ATXN2 Variants: Insights From a Biallelic Trinucleotide Repeat Expansion in an Acadian Family.
    Neurology. Genetics· 2026· PMID 41630926mais citado
  5. Biallelic Novel SKOR2 Variants in Individuals With Cerebellar Hypoplasia and Intellectual Disability, Expanding the Phenotypic Spectrum of Valence-Farazi Cerebellar Ataxia Syndrome.
    American journal of medical genetics. Part A· 2026· PMID 41821366mais citado
  6. Mast cell mediators in hereditary angioedema.
    Orphanet J Rare Dis· 2026· PMID 41832580recente
  7. Prenatal Molecular Diagnosis of COL2A1-Associated Stickler Syndrome: Genotype-Phenotype Correlation in a Resource-Limited Healthcare Setting.
    Int J Mol Sci· 2026· PMID 41828453recente
  8. Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.
    Orphanet J Rare Dis· 2026· PMID 41827036recente
  9. The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
    Orphanet J Rare Dis· 2026· PMID 41821052recente
  10. Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center.
    Orphanet J Rare Dis· 2026· PMID 41821046recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:369847(Orphanet)
  2. MONDO:0018243(MONDO)
  3. GARD:21579(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q56014119(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento intelectual-movimentos hipercinéticos-ataxia do tronco

ORPHA:369847 · MONDO:0018243
Prevalência
<1 / 1 000 000
Casos
5 casos conhecidos
Herança
Autosomal recessive
CID-10
G25.5 · Outras formas de coréia
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5192595
Wikidata
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades